Carve-in evidence continues to build

Linking pharmacy and medical benefits in one contract is better for the bottom line.

June 1, 2020
Pharmacy Benefit Carve-in Versus Carve-out: Cost and Medical Events Two-year Retrospective Cohort Study (Fall 2020)

Related news

Perspectives

November 29, 2023

Traditional Drug Pipeline Monthly Update: November 2023

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…

Perspectives

November 29, 2023

Specialty Drug Pipeline Monthly Update: November 2023

This monthly pipeline wrap-up provides a review of newly approved specialty drugs, recent…

Perspectives

November 16, 2023

2023 NHCAA Rewind – The Prime/MRx Special Investigations Unit is Prepped to Explore the Frontier of Fraud  

Earlier this month, the Prime Therapeutics/Magellan Rx (Prime/MRx) Special Investigations Unit (SIU) and…